- Find
- Manage
- Resources
Migraine Drugs
MAP's drug, Levadex, showed statistical significance at two hours compared to placebo at relieving common symptoms of migraine: pain, nausea, and sensitivity to light and sound.
Levadex, formerly called MAP0004, also reached secondary measures of the 792-patient trial, including pain relief at 30 minutes and sustained relief for 48 hours.
Read moreMore information on "Migraine Drugs"
From Our Experts
Migraine Drugs: From Clinical Trial to Drug Approval
Here on MyMigraineConnection.com, a lot of the discussions, questions, and articles are about medications for Migraines and headaches.... Read more »
New Migraine Drug Telcagepant Delayed
Merck & Company's new Migraine drug Telcagepant which was recently hoping to win FDA approval, has been delayed. The small phase... Read more »
Supplements for Migraine: They ARE Drugs
When it comes to Migraines and medications, I don't know anyone who wouldn't prefer to use only "natural" treatments (or better yet, none... Read more »
New Migraine Drug Levadex Performs Well in Trial
Phase III clinical trials for Levadex, a new Migraine abortive medication are progressing well. Levadex, from MAP Pharmaceuticals, has... Read more »
Migraine with aura only -- any drugs that make the aura disappear?
Full Question: migraine with aurasHi, I've had migraines w/auras since childhood. I only get them once or twice a year but only get the... Read more »
From Our Sources
Migraine Drug Linked to Oral Birth Defects
The epilepsy and migraine drug Topamax appears to increase the risk for oral birth defects in women taking the medication, a new study has found. The... Read more »
New migraine drug shows promise in trial
A new drug called tonabersat has shown positive results for preventing migraine with aura in a new study, its maker has reported. Tonabersat was able... Read more »
New Migraine Drug May Help Those Who Can't Take Triptans
An experimental migraine treatment called telcagepant may offer hope for migraine patients who don't respond to older drugs. An online review in the... Read more »
New migraine drugs may have new target
Scientists say they may have found a new "target" for future migraine medicines. New research published in the medical journal The Lancet suggest... Read more »
Migraine drug tonabersat fails in latest trial
Drugmaker Minister Pharmaceuticals is reporting that its new migraine medicine, tonabersat, has failed in a mid-stage clinical trial. Company... Read more »
Featuring Content From:
By using this service, you accept our Terms of Use. Please read them. The consumer health information on is for informational purposes only and is not a substitute for medical advice or treatment for any medical conditions. You should promptly seek professional medical care if you have any concern about your health, and you should always consult your physician before starting a fitness regimen. Copyright © 2012 Remedy Health Media, LLC. All Rights Reserved.
